This work is licensed under a Creative Commons Attribution 4.0 International License.
General Information
DRACP ID DRACP04168
Peptide Name
Sequence VKAWAKVLKGFGKLLKGFGKL
Sequence Length 21
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C113H186N28O22
Absent amino acids CDEHIMNPQRSTY
Common amino acids K
Mass 264583
Pl 11.5
Basic residues 6
Acidic residues 0
Hydrophobic residues 11
Net charge 6
Boman Index 1013
Hydrophobicity 32.86
Aliphatic Index 111.43
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 5500
Absorbance 280nm 275
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 30506920
Title Simulated Molecular Evolution for Anticancer Peptide Design
Doi Not available
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 17986
This work is licensed under a Creative Commons Attribution 4.0 International License.